HEALTHEURACTIV
Closing the Gap Between Innovation and Access in Myasthenia Gravis Care [Promoted Content]
New therapies are transforming generalized myasthenia gravis care, but unequal access across Europe hinders patient outcomes. Improved diagnosis, specialist referrals, and consistent care access could enhance health system resilience and economic sustainability.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Astellas treatment offers new hope to a devastated rare disease community
- Personalized CRISPR therapies could soon reach thousands — here’s how
- Tanzania: Moi Rolls Out Robotic Surgery Revolution in Tanzania
- Telangana Health Minister announces wider access to Emicizumab for haemophilia patients
- New Strategies and Platforms for Gastroesophageal Cancer